| Immune checkpoint inhibitors: an emerging cause of insulin-dependent diabetes |
30 |
| Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7-9 years of age |
28 |
| New directions in incidence and prevalence of diagnosed diabetes in the USA |
14 |
| Treatment choice, medication adherence and glycemic efficacy in people with type 2 diabetes: a UK clinical practice database study |
13 |
| Impact of pharmacological treatment of diabetes mellitus on dementia risk: systematic review and meta-analysis |
12 |
| Declining trends of diabetic nephropathy, retinopathy and neuropathy with improving diabetes care indicators in Japanese patients with type 2 and type 1 diabetes (JDDM 46) |
11 |
| Exercise modes and their association with hypoglycemia episodes in adults with type 1 diabetes mellitus: a systematic review |
10 |
| Effects of metformin, acarbose, and sitagliptin monotherapy on gut microbiota in Zucker diabetic fatty rats |
10 |
| Relationships of surrogate indexes of insulin resistance with insulin sensitivity assessed by euglycemic hyperinsulinemic clamp and subclinical vascular damage |
8 |
| Improved well-being and decreased disease burden after 1-year use of flash glucose monitoring (FLARE-NL4) |
8 |
| Medical nutrition therapy for gestational diabetes mellitus based on Mediterranean Diet principles: a subanalysis of the St Carlos GDM Prevention Study |
8 |
| Inpatient diabetes management by specialized diabetes team versus primary service team in non-critical care units: impact on 30-day readmission rate and hospital cost |
8 |
| Diabetes risk score in the United Arab Emirates: a screening tool for the early detection of type 2 diabetes mellitus |
8 |
| Real-world crude incidence of hypoglycemia in adults with diabetes: Results of the InHypo-DM Study, Canada |
8 |
| Flash glucose monitoring improves glycemia in higher risk patients: a longitudinal, observational study under real-life settings |
8 |
| Association of socioeconomic status and DKA readmission in adults with type 1 diabetes: analysis of the US National Readmission Database |
8 |
| Incorporating patients' perspectives into the initial stages of core outcome set development: a rapid review of qualitative studies of type 2 diabetes |
7 |
| Health-related quality of life and its associated factors among adult patients with type II diabetes attending Mizan Tepi University Teaching Hospital, Southwest Ethiopia |
7 |
| Plant-derived polyunsaturated fatty acids and markers of glucose metabolism and insulin resistance: a meta-analysis of randomized controlled feeding trials |
7 |
| Insomnia is associated with an increased risk of type 2 diabetes in the clinical setting |
7 |
| Medication regimen complexity and its impact on medication adherence and glycemic control among patients with type 2 diabetes mellitus in an Ethiopian general hospital |
7 |
| Unilateral remote temperature monitoring to predict future ulceration for the diabetic foot in remission |
7 |
| Sodium glucose co-transporter 2 inhibitors and cardiovascular event protections: how applicable are clinical trials and observational studies to real-world patients? |
7 |
| 'MOVEdiabetes': a cluster randomized controlled trial to increase physical activity in adults with type 2 diabetes in primary health in Oman |
6 |
| Impact of glycemic traits, type 2 diabetes and metformin use on breast and prostate cancer risk: a Mendelian randomization study |
6 |
| Experimental modeling of cornea wound healing in diabetes: clinical applications and beyond |
6 |
| Glucagon-like peptide-1 receptor agonists are not associated with retinal adverse events in the FDA Adverse Event Reporting System |
6 |
| Development and validation of a prediction model for insulin-associated hypoglycemia in non-critically ill hospitalized adults |
6 |
| GOAL study: clinical and non-clinical predictive factors for achieving glycemic control in people with type 2 diabetes in real clinical practice |
6 |
| Eligibility of patients with type 2 diabetes for sodium-glucose cotransporter 2 inhibitor cardiovascular outcomes trials: a global perspective from the DISCOVER study |
6 |
| Total energy expenditure is comparable between patients with and without diabetes mellitus: Clinical Evaluation of Energy Requirements in Patients with Diabetes Mellitus (CLEVER-DM) Study |
6 |
| Urinary adiponectin as a new diagnostic index for chronic kidney disease due to diabetic nephropathy |
6 |
| Association of serum orosomucoid with 30-min plasma glucose and glucose excursion during oral glucose tolerance tests in non-obese young Japanese women |
5 |
| Validity of ICD-10-CM codes for determination of diabetes type for persons with youth-onset type 1 and type 2 diabetes |
5 |
| Selenium supplementation and insulin resistance in a randomized, clinical trial |
5 |
| Relationship between baseline physical activity assessed by pedometer count and new-onset diabetes in the NAVIGATOR trial |
5 |
| Senescence marker activin A is increased in human diabetic kidney disease: association with kidney function and potential implications for therapy |
5 |
| Pharmacovigilance assessment of the association between Fournier's gangrene and other severe genital adverse events with SGLT-2 inhibitors |
5 |
| Clinical and economic outcomes among injection-naive patients with type 2 diabetes initiating dulaglutide compared with basal insulin in a US real-world setting: the DISPEL Study |
5 |
| Nationwide trends in the epidemiology of diabetic foot complications and lower-extremity amputation over an 8-year period |
5 |
| Factors influencing variation in participation in the National Diabetes Audit and the impact on the Quality and Outcomes Framework indicators of diabetes care management |
4 |
| Hepatic fat and glucose tolerance in women with recent gestational diabetes |
4 |
| Is chronic low back pain a risk factor for diabetes? The Nord-Trondelag Health Study |
4 |
| Impact of a structured patient support program on adherence and persistence in basal insulin therapy for type 2 diabetes |
4 |
| Trimethylamine N-oxide and incident atherosclerotic events in high-risk individuals with diabetes: an ACCORD trial post hoc analysis |
4 |
| Retinopathy progression and the risk of end-stage kidney disease: results from a longitudinal Japanese cohort of 232 patients with type 2 diabetes and biopsy-proven diabetic kidney disease |
4 |
| Validity of the FINDRISC as a prediction tool for diabetes in a contemporary Norwegian population: a 10-year follow-up of the HUNT study |
4 |
| Empagliflozin reverses obesity and insulin resistance through fat browning and alternative macrophage activation in mice fed a high-fat diet |
4 |
| Plasma fibroblast growth factor 21 levels increase with ectopic fat accumulation and its receptor levels are decreased in the visceral fat of patients with type 2 diabetes |
4 |
| Dietary intake and eating patterns of young children with type 1 diabetes achieving glycemic targets |
4 |
